Coverage with evidence development for medical devices in Central and Eastern Europe

The value of medical devices caries with it less certainty than pharmaceuticals for a variety of reasons.  As described in Kovács et al. (2022) medical devices: often have multiple applications, frequently, undergo product modifications and during their product lifecycle, multiple incremental technological innovations take place affecting both clinical and economic consequences of their adoption into…

Obamacare’s slow repeal?

While we are waiting for the King v. Burwell verdict, which could repeal large sections of Obamacare, the house of representatives has already approved rolling back some ACA provisions. Modern Healthcare reports: Lawmakers postponed final passage of the proposed Protecting Seniors’ Access to Medicare Act despite a majority voting in favor of the bill. The…

New Icon of Medicine: The Stetho-phone?

The stethoscope has been the icon of medicine for 200 years. Shouldn’t we be able to have built a better device by now? In fact, an improved stethoscope exists. The Atlantic describes a new technology that combines a stethoscope and smartphone technology. The CardioSleeve, a new, FDA-approved accessory, transforms a standard analog stethoscope into a…

Device Pricing Policies in the U.S. and Europe

How do public payers set device reimbursement in the U.S. and Europe?  A Health Affairs article by Sorenson, Drummond and Burns answers this question. Compared to the United States, Europe more formally and consistently considers value to determine which technologies to cover and at what price, especially for complex, costly devices. Both the United States and Europe have…